StockWatch
·
COROMANDEL · Q1 FY27 · THE VERDICT

Growth masks margin squeeze; subsidy revision now critical

Revenue climbed 15.9% to ₹8,165 Cr, but PAT collapsed 23.9% to ₹382 Cr and EBITDA flatlined despite price hikes. The margin crisis is real—and depends entirely on government action by Kharif.

Q1 FY27 resultsCOROMANDELCOROMANDEL INTERNATIONAL LTD.02 Aug 2026 · 6 min read
Revenue

₹8,165 Cr

+15.9% YoY

PAT

₹382 Cr

-23.9% YoY

EBITDA

₹761 Cr

-3% YoY (flat)

Net margin

4.6%

vs. 6.1% prior year

The quarter exposed a hard limit: management can raise prices, but subsidy policy sets the floor on viability. Revenue up 16%, yet profit down 24%. EBITDA flat. The company delivered exactly what it promised the Street — but what it promised does not work without a government action that has not yet materialized.

The paradox: Why strong sales delivered weak profit

Fertilizer business delivered ₹8,055 Cr in revenue (77% of total consolidated), up 14% YoY. But the business ran at only 72% capacity (production 6.9 lakh tons vs. 8.4 lakh ton run-rate), and EBITDA from the segment was ₹761 Cr — essentially flat year-on-year despite the sales uplift. The math: company raised prices 25–30% across fertilizer grades this season. Volumes down 9–10%. Costs (ammonia, sulphur) held elevated. Subsidy received during the quarter, ₹1,392 Cr, was up 7% from ₹1,300 Cr in Q1 prior year. But outstanding subsidy as of June 30 stood at ₹3,254 Cr, and — crucially — Kharif rates had not yet been revised upward to reflect the Middle East crisis-driven inflation in raw materials.

Non-subsidy segments compensated: Crop Protection revenue ₹870 Cr (+20% YoY), EBIT ₹159 Cr (+44%). Retail revenue surged 85% on expanded network (1,200+ outlets, 76% unit profitability). But the fertilizer PAT collapse (driven by EBITDA compression and higher depreciation from backward integration capex commissioning) more than offset the wins.

Management claims: Graded against delivered results

The gap between narrative and numbers

Fertilizer business delivered very strong numbers in spite of headwinds

Overstated

Revenue +15.9%, but volumes down 9–10%, EBITDA flat ₹761 Cr vs. ₹782 Cr, PAT −24%

Crop Protection delivered record performance, revenue up 20% to ₹870 Cr, EBIT +44% to ₹159 Cr

Supported

Actual results match claim exactly: ₹870 Cr revenue, ₹159 Cr EBIT confirmed

Backward integration will drive EBITDA per ton from ₹5,000 to ₹6,500 once normalized

Contradicted

Q1 shows compression, not expansion. Target is aspirational; depends on subsidy revision & input normalization not yet delivered

Industry maintained consumption sales volumes despite subsidy lag

Supported

Consumption stable, farmers picked lower MRP packs early; point-of-sales up 13% to 7.9 lakh tons

What changed on this call

Subsidy revision hung: The company prior-call assumption was a 10% hike in NP/NPK subsidy rates. Instead, rates announced do not factor the Middle East crisis inflation. Industry production and imports fell 21% and 38% YoY respectively. Management is now in a holding pattern—prices already at ceiling, production throttled, waiting for policy to move. No timeline given; hedged language ('hopeful outcome coming').

Raw material inflation accelerated: Ammonia and sulphur remain elevated. Phosphoric acid Q2 settled at $1,700/ton vs. ₹1,360 Q1 (+25%). Management stated sulphur expected to remain high 'for some time,' declined to accept more supply at current levels. This is a downgrade from prior call's assumption of moderation.

Crop Protection momentum stronger: Guided 20–25% growth; delivered 20%, at the lower end. But EBIT +44% outpaced revenue growth due to better product mix and pricing power. Retail network now 1,200 outlets vs. prior baseline. This segment is compensating for fertilizer headwinds.

Backward integration on track, margin uplift deferred: PA-SA plants (phosphoric acid–sulphuric acid) commissioned as planned, stabilized in operations. Senegal BMCC mining producing 1.1 lakh tons rock phosphate (on plan). Granulation project commencing Q4. But management explicitly said the ₹5,000 → ₹6,500 EBITDA/ton journey depends on subsidy revision and input cost normalization — neither yet delivered. It's no longer 'next quarter' but 'normal situation required'.

The bull-bear ledger

What holders should track for and against
  • Non-subsidy segments firing (CP +20%, Retail +85%, Specialty 25–30% growth YoY) — real diversification kicking in

  • Market share gains in primary fertilizer (22% vs. 18%) despite volume moderation — competitive moat intact

  • Backward integration capex now live (PA-SA, granulation Q4, Senegal mining); reduces raw material cost risk over time

  • PAT down 24% YoY despite 16% revenue growth — profitability has decoupled from topline

  • Subsidy revision (core assumption) not received; fertilizer production constrained to 72% capacity utilization

  • Outstanding subsidy ₹3,254 Cr as of June 30; working capital dynamics tied to government timing, not company execution

  • Management tone defensive; hedged language on subsidy ('hopeful') and inflation ('don't expect this quarter'; 'normal situation required')

Risks, ranked by holder concern

What could derail the recovery thesis

Subsidy revision delayed past Kharif season (Aug–Sep 2026)

HIGH

Core assumption for volume recovery and margin stabilization. Without revision by monsoon season peak, fertilizer demand likely softens further (already 9–10% volume decline Q1). Further production cuts forced; price destruction risk.

Raw material inflation sustained longer than expected (sulphur, ammonia, phosphoric acid)

HIGH

Company already taken 25–30% price increases; farmer and channel affordability at ceiling. No more pricing room. If raw material costs stay elevated Q2+, margin compression worsens or demand destroys to offset cost.

Monsoon deficit persists (23% deficit early June, moderated to 17% by end; reservoir 34% capacity vs. 57% prior year)

MEDIUM

Kharif sowing momentum already visible, but sustained drought could dampen fertilizer offtake in Q2–Q3. Farmer purchase power weakens in drought years; shifts to cheaper grades or DAP (lower subsidy dependency for government but margin headwind for NPK producers).

Demand elasticity to price hikes exceeds company estimate (farmers shift to DAP or skip nutrient application)

MEDIUM

Management resisted analyst suggestion of demand destruction but acknowledged it 'can happen' if subsidy not corrected. Retail network (1,200 outlets) gives direct visibility, but large agri-dealer channel may see parallel-import or lower-MRP routing.

Capex ROI from backward integration disappoints (PA-SA acid costs don't decline as modeled; Senegal SSP business slow to scale)

MEDIUM

INR7,000 Cr invested over 3–4 years; management now focused on 'cash generation first' (language suggests capex ROI scrutiny). If ₹5,000 → ₹6,500 EBITDA/ton uplift doesn't materialize, return on equity will compress.

How the Street is positioned

Stock down 17.02% from its all-time high of ₹2,499, now at ₹2,073.6. The day-1 post-result reaction was negative (−2.08%), a candid assessment of the PAT collapse; by day 5, the decline had moderated to +1.55%, suggesting partial recovery of confidence. The stock remains above its 20-day (₹2,038.74) and 50-day (₹1,958.53) simple moving averages but below the 200-day (₹2,115.49), placing it in a 'correction within an uptrend' posture.

Institution flows hint at caution. FII holdings declined 78 basis points to 13.02% in Q4 FY26 (from 14.29% a year earlier), while DII holdings rose 150 basis points to 18.20%. The shift suggests foreign portfolio investors are trimming exposure while domestic institutions (likely long-only funds) are adding on dips — a classic pattern when fundamentals are cloudy but near-term catalysts (subsidy revision) are material. Promoter shareholding stable at 56.35%.

The valuation drawdown is justified by the earnings miss — PAT down 24% is not a market overreaction. However, the stock's trading above key moving averages (20/50) signals the Street still expects a recovery if subsidy rates are revised by Kharif.

The debate

What to watch next

Catalysts that move the needle
  • 1 · Kharif subsidy rate announcement (Aug–Sep 2026)

    Management awaiting finalization of NP/NPK rates. If announced in line with ammonia/sulphur inflation (target ₹6,000–₹7,000 EBITDA/ton for viability), volume recovery and margin stabilization follow. Timing critical — delayed past September softens demand signal.

  • 2 · Q2 phosphoric acid pricing (expected ~$1,700 vs. Q1 $1,360)

    Already marked up 25%. Will determine whether PA-SA backward integration capex begins yielding cost savings or if acid sourcing costs remain a margin headwind. Management expects 'softening' but timeline vague.

  • 3 · Granulation project commissioning (Q4 FY27)

    Capacity unlock for 750K ton NPK sales via retail (500K tons) and wholesale/new markets (350–400K tons). Volume recovery lever; depends on subsidy normalization to make economics work.

  • 4 · Monsoon outturn and Kharif sowing momentum (Jul–Aug 2026)

    Deficit has moderated (23% → 17%), and sowing picking up. Full-quarter normalization would signal on-ground demand recovery and validate subsidy revision assumption.

The number to track from here

Fertilizer EBITDA per ton — target ₹6,500 vs. current ~₹5,000. It's the single best proxy for whether the subsidy + backward integration thesis is working. Q1 showed compression, not expansion. If Q2 shows year-over-year expansion (even small, to ₹5,200–₹5,300/ton), it signals subsidy revision + input stabilization are real. If Q2 stays flat or compresses further, the recovery is being pushed to Q3+ and risk rises. Pair it with capacity utilization — back above 90% would confirm demand recovery; stuck at 75%+ signals structural weakness.

Coromandel is not in distress. Crop Protection and Retail are maturing into genuine growth engines. Backward integration capex will compound over 2–3 years. The issue is immediate: Q2 and Q3 profitability hang on a subsidy revision that the company does not control. Management has been honest about the constraints — price hikes taken, production throttled, waiting for policy. The market's 17% drawdown from ATH is fair; it reflects the earnings reality. What's mispriced is the recovery probability — it's not 'if' subsidy gets revised but whether it gets revised *in time* to stabilize Q2–Q3 volumes before seasonal demand peaks and monsoons peak. Watch the government announcement in the next 3–4 weeks. Until then, hold.

Informational and educational content only. Not investment advice.